Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
that data will be shared on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing during two poster presentations at the 2026 ASCO Gastrointestinal Cancers Symposium, being held January 8-10, 2026 in San Francisco, CA., and online. The studies evaluate the use of ctDNA in colorectal cancer using the Haystack MRD® test from Quest Diagnostics. Details of the poster presentations are as follows: Title: Reproducibility and Clinical Concordance of a Tumor-Informed MRD Assay in Patients with Resected Colorectal Cancer from the DYNAMIC Trials Abstract Number: Lead Author: Jeanne Tie, MBChB, FRACP, MD Session Time and Date: 1/10/2026, 12:00 PM-1:30 PM (PST) Title: Use of circulating tumor DNA (ctDNA) to monitor patients undergoing total neoadjuvant treatment (TNT) for locally advanced rectal adenocarcinoma (LARC). Abstract Number: Lead Author: Eric Christenson, MD Session Time and Date: 1/10/2026, 12:00 PM-1:30 PM (PST) About ctDNA MRD A growing body of re
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026PR Newswire
- Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs [Yahoo! Finance]Yahoo! Finance
- Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers SymposiumPR Newswire
- PracticeQ Partners With Fullscript to Streamline Lab Testing and Improve Patient Care [Yahoo! Finance]Yahoo! Finance
- What You Need To Know Ahead of Quest Diagnostics' Earnings Release [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 10/21/25 - Beat
DGX
Sec Filings
- 11/28/25 - Form 4
- 11/28/25 - Form 4
- 11/25/25 - Form 144
- DGX's page on the SEC website